• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学证据支持在正常血压的猪模型中成功的射频肾去神经支配的持久性。

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model.

机构信息

University Hospital of Wales, Cardiff, UK.

Medtronic, Santa Rosa, California, USA.

出版信息

J Hypertens. 2022 Oct 1;40(10):2068-2075. doi: 10.1097/HJH.0000000000003236. Epub 2022 Jul 18.

DOI:10.1097/HJH.0000000000003236
PMID:35866489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9451943/
Abstract

BACKGROUND

Sustained blood pressure reductions after radiofrequency (RF) renal denervation (RDN) have been reported to 3 years in patients with uncontrolled hypertension. However, mechanistic data to support procedural durability are lacking. We aimed to quantify the long-term nerve anatomic and functional effects of RF RDN in a preclinical model.

METHODS

Bilateral RF RDN was performed in 20 normotensive swine. Renal tissue samples were obtained in the RDN-treated groups at 7 ( n  = 6), 28 ( n  = 6), and 180 days ( n  = 8) postprocedure for quantification of cortical norepinephrine (NE) levels and renal cortical axon density. Tissue fibrosis, necrosis and downstream nerve fiber atrophy (axonal loss) were also scored for each sample. Three additional untreated groups ( n  = 6, n  = 6 and n  = 8, respectively) served as control.

RESULTS

Pathologic nerve changes were characterized by necrosis in the ablated region at 7 days that partially resolved by 28 days and fully resolved at 180 days. Axonal loss was apparent within and downstream to the ablation regions and was evident at 7, 28 and 180 days in the main vessel and branch vessels. Consequently, renal cortical axon density and corresponding cortical NE levels were significantly reduced at 7 days in the RDN vs. control group and remained suppressed at 180 days.

CONCLUSIONS

Reductions in renal NE, cortical axon density and downstream axonal loss caused by axonal destruction persisted through 180 days post-RDN in a normotensive swine model. These results suggest functional nerve regrowth after RF RDN is unlikely and support published clinical evidence that the procedure results in durable blood pressure reduction.

摘要

背景

射频(RF)肾脏去神经(RDN)后持续的血压降低已在高血压未控制的患者中报告至 3 年。然而,缺乏支持程序耐久性的机制数据。我们旨在通过临床前模型来量化 RF RDN 的长期神经解剖和功能效果。

方法

在 20 名正常血压的猪中进行双侧 RF RDN。在手术后 7(n=6)、28(n=6)和 180 天(n=8)时,从 RDN 治疗组中获得肾组织样本,以定量测量皮质去甲肾上腺素(NE)水平和肾皮质轴突密度。还对每个样本的组织纤维化、坏死和下游神经纤维萎缩(轴突丢失)进行评分。另外三个未处理的组(n=6、n=6 和 n=8,分别)作为对照。

结果

病理性神经变化的特征是在消融区域的坏死,7 天后部分缓解,28 天后完全缓解。轴突丢失在消融区域内和下游可见,并在 7、28 和 180 天在主血管和分支血管中可见。因此,与对照组相比,RDN 组在 7 天时肾皮质 NE 和皮质轴突密度明显降低,且在 180 天时仍受到抑制。

结论

在正常血压的猪模型中,由轴突破坏引起的肾 NE、皮质轴突密度和下游轴突丢失的减少在 RDN 后持续 180 天。这些结果表明 RF RDN 后功能神经再生不太可能发生,并支持已发表的临床证据,即该手术可导致持久的血压降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/61f965dfb978/jhype-40-2068-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/c76352165ec1/jhype-40-2068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/fcaf7ae7e014/jhype-40-2068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/cd239ed1784f/jhype-40-2068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/5f6aba1e364f/jhype-40-2068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/9742be2b14cf/jhype-40-2068-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/5e6cecc1ead8/jhype-40-2068-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/61f965dfb978/jhype-40-2068-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/c76352165ec1/jhype-40-2068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/fcaf7ae7e014/jhype-40-2068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/cd239ed1784f/jhype-40-2068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/5f6aba1e364f/jhype-40-2068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/9742be2b14cf/jhype-40-2068-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/5e6cecc1ead8/jhype-40-2068-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f7e/9451943/61f965dfb978/jhype-40-2068-g007.jpg

相似文献

1
Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model.组织学证据支持在正常血压的猪模型中成功的射频肾去神经支配的持久性。
J Hypertens. 2022 Oct 1;40(10):2068-2075. doi: 10.1097/HJH.0000000000003236. Epub 2022 Jul 18.
2
Translational value of preclinical models for renal denervation: a histological comparison of human versus porcine renal nerve anatomy.临床前模型在肾脏去神经支配中的转化价值:人类与猪肾脏神经解剖结构的组织学比较。
EuroIntervention. 2023 Feb 6;18(13):e1120-e1128. doi: 10.4244/EIJ-D-22-00369.
3
Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model.猪模型中基于化学和射频的肾去神经支配的随机、盲法和对照比较研究。
EuroIntervention. 2017 Feb 3;12(15):e1898-e1906. doi: 10.4244/EIJ-D-16-00206.
4
Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.基于导管的射频肾去神经术的病变位置对疗效和安全性的影响。
J Am Coll Cardiol. 2015 Oct 20;66(16):1766-1775. doi: 10.1016/j.jacc.2015.08.018.
5
Renal Sympathetic Denervation System via Intraluminal Ultrasonic Ablation: Therapeutic Intravascular Ultrasound Design and Preclinical Evaluation.经腔内超声消融的肾交感神经去支配系统:治疗性血管内超声设计与临床前评估
J Vasc Interv Radiol. 2017 May;28(5):740-748. doi: 10.1016/j.jvir.2017.01.015. Epub 2017 Mar 3.
6
Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.支架置入后肾动脉内导管射频消融去肾神经术的疗效和安全性。
Circ Cardiovasc Interv. 2014 Dec;7(6):813-20. doi: 10.1161/CIRCINTERVENTIONS.114.001506. Epub 2014 Oct 21.
7
Long-Term Safety and Efficacy of Transcatheter Microwave and Radiofrequency Denervation in a Chronic Ovine Model.经皮微波和射频消融治疗慢性羊模型的长期安全性和有效性。
J Am Heart Assoc. 2024 May 7;13(9):e031795. doi: 10.1161/JAHA.123.031795. Epub 2024 Apr 25.
8
Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model.两种射频肾动脉去神经导管在猪模型中预测肾去神经治疗效果的程序和解剖学因素。
J Hypertens. 2018 Dec;36(12):2453-2459. doi: 10.1097/HJH.0000000000001840.
9
Safety of catheter-based radiofrequency renal denervation on branch renal arteries in a porcine model.基于导管的射频肾动脉去神经支配在猪模型中分支肾动脉的安全性。
Catheter Cardiovasc Interv. 2019 Feb 15;93(3):494-502. doi: 10.1002/ccd.27953. Epub 2018 Nov 8.
10
Acute changes in morphology and renal vascular relaxation function after renal denervation using temperature-controlled radiofrequency catheter.使用温控射频导管进行肾去神经支配后肾脏形态和肾血管舒张功能的急性变化。
BMC Cardiovasc Disord. 2019 Mar 22;19(1):67. doi: 10.1186/s12872-019-1053-z.

引用本文的文献

1
Safety and Efficacy of Renal Denervation for the Treatment of Resistant Hypertension in Patients with Chronic Kidney Disease: A Narrative Review of the Literature.肾脏去神经支配治疗慢性肾脏病患者顽固性高血压的安全性和有效性:文献综述
Biomedicines. 2025 Aug 9;13(8):1951. doi: 10.3390/biomedicines13081951.
2
Cost-Effectiveness of Radiofrequency Renal Denervation in Taiwan Based on Clinical Evidence and Regional Event Rates.基于临床证据和地区事件发生率的台湾地区肾动脉射频消融术的成本效益分析
J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70090. doi: 10.1111/jch.70090.
3
Efficacy and Safety of Catheter-Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta-Analysis.
基于导管的肾去神经术治疗高血压患者的疗效与安全性:一项系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70080. doi: 10.1111/jch.70080.
4
The efficacy of Netrod Six-electrode Radiofrequency Renal Denervation system: mathematical modeling, phantom experiments and animal studies.Netrod六电极射频肾去神经支配系统的疗效:数学建模、体模实验和动物研究。
PLoS One. 2025 May 27;20(5):e0323336. doi: 10.1371/journal.pone.0323336. eCollection 2025.
5
Preclinical Evaluation of a Novel Cryo Renal Denervation System.新型冷冻肾去神经支配系统的临床前评估
JACC Basic Transl Sci. 2025 Feb 21;10(6):745-54. doi: 10.1016/j.jacbts.2025.01.014.
6
Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program.在SYMPLICITY临床试验项目中对肾交感神经射频消融术进行的长期、患者层面分析
JACC Adv. 2025 Mar;4(3):101606. doi: 10.1016/j.jacadv.2025.101606. Epub 2025 Feb 21.
7
Balancing Affordability and Need: Should We Use Renal Denervation in Hypertension Management?平衡可承受性与需求:我们是否应在高血压管理中使用肾去神经支配术?
J Soc Cardiovasc Angiogr Interv. 2024 Aug 13;3(10):102248. doi: 10.1016/j.jscai.2024.102248. eCollection 2024 Oct.
8
Catheter-Based Radiofrequency Renal Denervation in the United States: A Cost-Effectiveness Analysis Based on Contemporary Evidence.美国基于导管的射频肾去神经术:基于当代证据的成本效益分析。
J Soc Cardiovasc Angiogr Interv. 2024 Aug 13;3(10):102234. doi: 10.1016/j.jscai.2024.102234. eCollection 2024 Oct.
9
The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined.肾去神经术治疗高血压及其他疾病(心力衰竭)之路:二十年的失败、成功与待决之事。
Heart Fail Rev. 2025 Mar;30(2):293-314. doi: 10.1007/s10741-024-10463-1. Epub 2024 Nov 7.
10
Response to 'Why the lack of enthusiasm for renal denervation?'.对“为何对肾去神经支配缺乏热情?”的回应。
J Hypertens. 2024 Dec 1;42(12):2215-2217. doi: 10.1097/HJH.0000000000003867. Epub 2024 Oct 31.